Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingyue Luo

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Immunopharmacology|April 22, 2025
Development and validation of a CT-based radiomics machine learning model for differentiating immune-related interstitial pneumoniaTingyue Luo, Jingze Guo, Junjie Xi, et al.
Immunobiology|February 22, 2025
Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapyTingyue Luo, Weisheng Chen, Danhui Huang, et al.
Journal of Internal Medicine|October 26, 2022
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemiaGuangyang Weng, Yu Zhang, Guopan Yu, et al.
Cancer Medicine|July 16, 2025
Heterogeneity of Checkpoint Inhibitor-Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical OutcomesTingyue Luo, Tiantian Liu, Weisheng Chen, et al.
Translational Lung Cancer Research|June 19, 2025
Construction of a checkpoint inhibitor-related pneumonia diagnostic model based on exhaled nitric oxide: a prospective observational studyYimei Gao, Tingyue Luo, Danhui Huang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Immunopharmacology|April 22, 2025
Development and validation of a CT-based radiomics machine learning model for differentiating immune-related interstitial pneumoniaTingyue Luo, Jingze Guo, Junjie Xi, et al.
Immunobiology|February 22, 2025
Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapyTingyue Luo, Weisheng Chen, Danhui Huang, et al.
Journal of Internal Medicine|October 26, 2022
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemiaGuangyang Weng, Yu Zhang, Guopan Yu, et al.
Cancer Medicine|July 16, 2025
Heterogeneity of Checkpoint Inhibitor-Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical OutcomesTingyue Luo, Tiantian Liu, Weisheng Chen, et al.
Translational Lung Cancer Research|June 19, 2025
Construction of a checkpoint inhibitor-related pneumonia diagnostic model based on exhaled nitric oxide: a prospective observational studyYimei Gao, Tingyue Luo, Danhui Huang, et al.
Pageof 2